MedPath

The effect of GM-CSF cytokine on sperm

Not Applicable
Conditions
Male factor infertility, evaluation of the effect of GM-CSF.
Registration Number
IRCT20200519047508N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
40
Inclusion Criteria

Men with semen parameters such as sperm count, motility and morphology, lower than WHO reference values
Men with Obstructive Azoospermia

Exclusion Criteria

Women over the age of 35, endometriosis, Polycystic ovary syndrome, Recurrent miscarriage

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sperm motility. Timepoint: Assessments of sperm motility at the beginning of the study and after incubation in both intervention and control groups. Method of measurement: Optical microscope.;Mitochondrial membrane potential of sperm. Timepoint: Measurement of mitochondrial membrane potential after incubation in both intervention and control groups. Method of measurement: Jc- 1, Flow cytometry.;Sperm DNA fragmentation. Timepoint: Measurement of sperm DNA fragmentation after incubation in both intervention and control groups. Method of measurement: TUNEL method.;Fertilization Rate. Timepoint: 24 hours after ICSI procedure. Method of measurement: View of 2 pronucleus with invert microscope.;Quality of embryo. Timepoint: Three days post-oocyte retrieval. Method of measurement: Using a three-point scoring system including fragmentation rate, number of blastomere, shape and size.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath